Baxter International market cap BAX
Share price times shares outstanding: what the whole company sells for, since 2009.
- Today, Oct 23, 2026
- $13.1B
- Highest close in our data
- $47.6B
- Feb 2020
Baxter International is worth $13.1B at the close on Oct 23, 2026, at $25.30 a share.
That is up 11% over the last year and down 67% over five years.
Its highest close in our data was $47.6B in Feb 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $13.1B | $8.2B | $14.2B | +31% |
| 2025 | $10B | $9.3B | $18.7B | −33% |
| 2024 | $14.9B | $14.9B | $22.2B | −24% |
| 2023 | $19.6B | $16.1B | $24.6B | −24% |
| 2022 | $25.7B | $25.1B | $43.8B | −40% |
| 2021 | $43B | $37B | $44.4B | +5% |
| 2020 | $41B | $38.4B | $47.6B | −4% |
| 2019 | $42.9B | $35.4B | $45.8B | +24% |
| 2018 | $34.7B | $33.2B | $41.5B | −1% |
| 2017 | $35.2B | $24.8B | $35.8B | +46% |
| 2016 | $24.1B | $19.2B | $26.5B | +16% |
| 2015 | $20.9B | $18.1B | $22.8B | −5% |
| 2014 | $22B | $19.6B | $22.6B | +7% |
| 2013 | $20.5B | $19.2B | $21.8B | +5% |
| 2012 | $19.6B | $14.7B | $20.5B | +29% |
| 2011 | $15.2B | $14.6B | $19.1B | −5% |
| 2010 | $16B | $13.2B | $20.2B | −17% |
| 2009 | $19.2B | $17.7B | $19.5B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Baxter International's size, closest first, today.
| Company | Market cap |
|---|---|
| BAXBaxter International | $13.1B |
| PENPenumbra | $12.8B |
| SOLVSolventum | $14.5B |
| COOCooper Companies | $11.6B |
| ALGNAlign Technology | $11B |
| GMEDGlobus Medical | $10.9B |
| PODDInsulet | $10.3B |
| MSAMSA Safety | $7B |
| WSTWest Pharmaceutical Services | $27.6B |
| MMSIMerit Medical Systems | $5.6B |
| HAEHaemonetics | $5.4B |
| Peer median | $11B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Baxter International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.